drugset / Trial / NCT01809964
Clinical Trial to Evaluate ANT-1401 in Crow's Feet
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to confirm the effect of ANT-1401 in the treatment of Lateral Canthal Lines.
Timeline
- Start
- 2013-03
- Primary completion
- 2013-06
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | — |